Analysis of association between butyrylcholinesterase K variant and apolipoprotein e genotypes in Alzheimer's disease

Neuroscience Letters

Volumn 371, Issue 2-3, 2004, Pages 142-146

  Raygani, Asad Vaisi ^a,b   Zahrai, Mahine ^a   Soltanzadeh, Akbar ^a   Doosti, Mahmood ^a   Javadi, Ebrahim ^a   Pourmotabbed, Tayebeh ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Aging; Alzheimer's disease; Apolipoprotein E; Butyrylcholinesterase K; Genetic polymorphism; Iranian; Tehran population; Variants

Indexed keywords

APOLIPOPROTEIN E; CHOLINESTERASE; CHOLINESTERASE K; UNCLASSIFIED DRUG;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BUTYRYLCHOLINESTERASE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; VARIATION (GENETICS);

EID: 7444260921     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.08.057     Document Type: Article

References (40)

1. O. Almkvist, T. Darreh-Shori, E. Stefanova, R. Spiegel, and A. Nordberg Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients Eur. J. Neurol. 11 4 2004 253 261
2. A. Alvarez-Arcaya, O. Combarros, J. Llorca, M. Sanchez-Guerra, J. Berciano, C. Fernandez-Viadero, and N. Pena The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer's disease in women Acta Neurol. Scand. 102 6 2000 350 353
3. C.F. Barters, F.S. Jensen, and O. Lockridge DNA mutation associated with the human BChE K-variant and its linkage to the atypical variant mutation and other polymorph sites Am. J. Hum. Genet. 50 1992 1086 1130
4. S. Bi, Y. Zhang, J. Wu, D. Wang, and Q. Zhao Association between low-density lipoprotein receptor-related protein gene, butyrylcholinesterase gene and Alzheimer' s disease in Chinese Chin. Med. Sci. J. 16 2 2001 71 75
5. N. Brindle, Y. Song, E. Rogaeva, S. Premkumar, G. Levesque, G. Yu, M. Ikeda, M. Nishimura, A. Paterson, S. Sorbi, R. Duara, L. Farrer, and P. St George-Hyslop Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease Hum. Mol. Genet. 7 5 1998 933 935
6. F. Crawford, D. Fallin, Z. Suo, L. Abdullah, M. Gold, A. Gauntlett, R. Duara, and M. Mullan The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations Neurosci. Lett. 1998 115 118
7. S. Dervish, D.L. Grantham, and D.A. Hopkins Distribution of butyrylcholinesterase in the human amygdale and hippocampal formation J. Comp. Neural. 393 1998 374 390
8. T. Erkinjuntti, I. Skoog, R. Lane, and C. Andrews Potential long-term effects of rivastigmine on disease progression may be linked to drug effects on vascular changes in Alzheimer brains Int. J. Clin. Pract. Nov. 57 9 2003 756 760
9. M.F. Folstein, S.E. Folstein, and P.R. McHugh Mini-Mental state. A practical method for grading the cognitive state of patients for the clinician J. Psychiatry Res. 12 1975 189 198
10. E. Ghebremedhin, D.R. Thal, C. Schultz, and H. Braak Age-dependent association between butyrylcholinesterase K-variant and Alzheimer disease-related neuropathology in human brains Neurosci. Lett. 1 320 2002 25 28
11. E. Giacobini Cholinergic function and Alzheimer's disease Int. J. Geriatr. Psychiatry 18 Suppl. 1 2003 51 55
12. E. Giacobini, P.l. Griffini, and T. Maggi Butyrylcholinesterase. Is it important for cortical acetylcholine regulation Neurotics Abstr. 22 1996 203
13. P. Gomez-Rooms, and C. Bourse Ultrastructural localization of butyrylcholinesterase on neurofibrillay degeneration sites in the brains of aged and Alzheimer's disease patients Brain Res. 640 1994 17 34
14. N.H. Greig, D.K. Lahiri, and K. Sambamurti Butyrylcholinesterase: an important new target in Alzheimer's disease therapy Int. Psychogeriatr. 14 2002 77 91
15. M. Gross-Bellard A rapid procedure for extracting genomic DNA from leukocytes by phenol chloroform Eur. J. Biochem. 36 1973 32 36
16. J.M. Grubber, A.M. Saunders, A.R. Crane-Gatherum, W.K. Scott, E.R. Martin, C.S. Haynes, P.M. Conneally, G.W. Small, A.D. Roses, J.L. Haines, and M.A. Pericak-Vance Analysis of association between Alzheimer disease and the K variant of butyrylcholinesterase (BCHE-K) Neurosci. Lett. 9 269 1999 115 119
17. J. Hosseini, F. Firuzian, and J. Feely Ethnic differences in the frequency distribution of serum cholinesterase activity Ir. J. Med. Sci. 100 1997 10 20
18. F.S. Jenese, L.R. Nielsen, and M. Schwartz Detection of the plasma cholinesterase K variant by PCR using amplification-created restriction site Hum. Heard. 46 1996 26 31
19. S.W.M. Johan, G. Weitzner, and R. Rozen A rapid procedure for extracting genomic DNA from leukocytes Nucleic Acids Res. 19 1991 408
20. P. Kehoe, H. Williams, P. Holmans, G. Wilcock, N.J. Cairns, J.M. Neal, and M.J. Owen The BChE-K variant and susceptibility to Alzheimer's disease J. Med. Gene 1998 35
21. C.S. Ki, D.L. Na, J.W. Kim, H.J. Kim, D.K. Kim, and B.K. Yoon No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease Am. J. Med. Genet. 16;88 2 1999 113 115
22. K.W. Kim, J.H. Jhoo, J.H. Lee, K.U. Lee, D.Y. Lee, J.C. Youn, J.Y. Youn, J.I. Woo, Neither the butyrylcholinesterase K variant nor transferrin C2 variant confers a risk for Alzheimer's disease in Koreans, J. Neural. 108 (10) (2001) 1159-1166.
23. S.M. Laws, B. Taddeik, C. Fisher, D. Small, R. Charnette, J. Hallmayers, W.S. Brooks, J.B.J. Kwok, P.R. Schofield, S.E. Gandy, and R.N. Martins Evidence that the butyrylcholinesterase K variant can protect against late-onset Alzheimer's disease Alzheimer Rep. 2 4 1999 210 223
24. D.W. Lee, H.C. Liu, T.Y. Liu, C.W. Chi, and C.J. Hong No association between butyrylcholinesterase K-variant and Alzheimer disease in Chinese Am. J. Med. Genet. 3 96 2000 167 170
25. D.J. Lehmann, C. Johnston, and A.D. Smith Synergy between the genes for butyrylcholinesterase K variant and Apolipoprotein E4 in late onset confirmed Alzheimer's disease Hum. Mol. Genet. 6 1997 1933 1936
26. D.J. Lehmann, Z. Nagy, Z. Litchfield, C.B. Borja, and A.D. Smith Association of butyrylcholinesterase K variant with cholinesterase positive neuritis plaques in the temporal cortex in late-onset Alzheimer's disease Hum. Genet. 106 2000 447 452
27. D.J. Lehmann, J. Williams, J. Mcbroom, and A.D. Smith Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer's disease and to identify high-risk subgroups Neuroscience 108 4 2001 541 554
28. G. Mckhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services task force of Alzheimer's disease Neurology 34 1984 939 944
29. S. Mcllory, P. Crawford, V.L.A. Dynan, K.B. McGleenon, B.M. Vahidarrs, D.M. Lawson, J.T. Passmore, and A.P. Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland J. Med. Genet. 37 2000 182 185
30. M. Mesulam, A. Guillozet, P. Shaw, and B. Quinn Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain Neurobiol. Dis. 9 1 2002 88 93
31. P.K. Panegyres, C.D. Mamotte, S.D. Vasikaran, S. Wilton, V. Fabian, and B.A. Kakulas Butyrycholinesterase K variant and Alzheimer's disease J. Neurol. 246 5 1999 369 370
32. E.K. Perry, R.H. Perry, and G. Blessed Changes in brain cholinesterase in senile dementia of Alzheimer type Neuropathol. Appl. Neurobiol. 4 1978 273 277
33. C. Russ, J. Powell, S. Lovestone, and C. Holmes K variant of butyrylcholinesterase and late-onset Alzheimer's disease Lancet 21;351 9106 1998 881
34. J. Saez-Valero, L.R. Fodero, M. Sjogren, N. Andreasen, S. Amici, V. Gallai, H. Vanderstichele, E. Vanmechelen, L. Parnetti, K. Blennow, and D.H. Small Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease J. Neurosci. Res. 1572 4 2003 520 526
35. A.B. Singleton, G. Smith, A.M. Gibson, R. Woodward, R.H. Perry, P.G. Ince, J.A. Edwardson, and C.M. Morris No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease Hum. Mol. Genet. 7 5 1998 937 939
36. W.J. Strittmattet, and A.D. Roses Apolipoprotein E and Alzheimer disease Proc. Natl. Acad. Sic. U.S.A. 92 47 1995 25 27
37. L. Tilley, K. Morgan, J. Grainger, P. Marsters, L. Morgan, J. Lowe, J. Xuereb, C. Wischik, C. Harrington, and N. Kalsheker Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease Eur. J. Hum. Genet. 7 6 1999 659 666
38. P.R. Wenham, W.H. Price, and G. Blandell Apolipoprotein E genotyping by one-stage PCR Lancet 337 1991 1158 1159
39. M. Whittaker Cholinesterase L. Beckman Monographs in Human Genetics vol. 11 1986 Karger Basel 1 125
40. H. Wiebusch, J. Poirier, P. Sevigny, and K. Schappert Further evidence for a synergistic association between ApoE epsilon4 and BChE-K in confirmed Alzheimer's disease Hum. Genet. 104 2 1999 158 163